AAAAAA
Results:
1-13
|
Results: 13
Authors:
Gardelle, O
Roelcke, U
Vontobel, P
Crompton, NEA
Guenther, I
Blauenstein, P
Schubiger, AP
Blattmann, H
Ryser, JE
Leenders, KL
Kaser-Hotz, B
Citation: O. Gardelle et al., [Br-76]bromodeoxyuridine PET in tumor-bearing animals, NUCL MED BI, 28(1), 2001, pp. 51-57
Authors:
Koerner, S
Schillinger, B
Vontobel, P
Rauch, H
Citation: S. Koerner et al., A neutron tomography facility at a low power research reactor, NUCL INST A, 471(1-2), 2001, pp. 69-74
Authors:
Dietz, M
Harder, S
Graff, J
Kunig, G
Vontobel, P
Leenders, KL
Baas, H
Citation: M. Dietz et al., Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[F-18]levodopa positron emission tomography in patients with Parkinson's disease, CLIN PHARM, 70(1), 2001, pp. 33-41
Authors:
Schillinger, B
Lehmann, E
Vontobel, P
Citation: B. Schillinger et al., 3D neutron computed tomography: requirements and applications, PHYSICA B, 276, 2000, pp. 59-62
Authors:
Kunig, G
Leenders, KL
Sanchez-Pernaute, R
Antonini, A
Vontobel, P
Verhagen, A
Gunther, I
Citation: G. Kunig et al., Benzodiazepine receptor binding in Huntington's disease: [C-11]flumazenil uptake measured using positron emission tomography, ANN NEUROL, 47(5), 2000, pp. 644-648
Authors:
Koerner, S
Lehmann, E
Vontobel, P
Citation: S. Koerner et al., Design and optimization of a CCD-neutron radiography detector, NUCL INST A, 454(1), 2000, pp. 158-164
Authors:
Bruehlmeier, M
Leenders, KL
Vontobel, P
Calonder, C
Antonini, A
Weindl, A
Citation: M. Bruehlmeier et al., Increased cerebral iron uptake in Wilson's disease: A Fe-52-citrate PET study, J NUCL MED, 41(5), 2000, pp. 781-787
Authors:
Sanchez-Pernaute, R
Kunig, G
Alba, AD
de Yebenes, JG
Vontobel, P
Leenders, KL
Citation: R. Sanchez-pernaute et al., Bradykinesia in early Huntington's disease, NEUROLOGY, 54(1), 2000, pp. 119-125
Authors:
Vollenweider, FX
Vontobel, P
Oye, I
Hell, D
Leenders, KL
Citation: Fx. Vollenweider et al., Effects of (S)-ketamine on striatal dopamine: a [C-11]raclopride PET studyof a model psychosis in humans, J PSYCH RES, 34(1), 2000, pp. 35-43
Authors:
Blasberg, RG
Roelcke, U
Weinreich, R
Beattie, B
von Ammon, K
Yonekawa, Y
Landolt, H
Guenther, I
Crompton, NEA
Vontobel, P
Missimer, J
Maguire, RP
Koziorowski, J
Knust, EJ
Finn, RD
Leenders, KL
Citation: Rg. Blasberg et al., Imaging brain tumor proliferative activity with [I-124]iododeoxyuridine, CANCER RES, 60(3), 2000, pp. 624-635
Authors:
Ametamey, SM
Samnick, S
Leenders, KL
Vontobel, P
Quack, G
Parsons, CG
Schubiger, PA
Citation: Sm. Ametamey et al., Fluorine-18 radiolabelling, biodistribution studies and preliminary pet evaluation of a new memantine derivative for imaging the NMDA receptor, J RECEPT SI, 19(1-4), 1999, pp. 129-141
Authors:
Weder, BJ
Leenders, KL
Vontobel, P
Nienhusmeier, M
Keel, A
Zaunbauer, W
Vonesch, T
Ludin, HP
Citation: Bj. Weder et al., Impaired somatosensory discrimination of shape in Parkinson's disease: Association with caudate nucleus dopaminergic function, HUM BRAIN M, 8(1), 1999, pp. 1-12
Authors:
Vollenweider, FX
Vontobel, P
Hell, D
Leenders, KL
Citation: Fx. Vollenweider et al., 5-HT modulation of dopamine release in basal ganglia in psilocybin-inducedpsychosis in man - A PET study with [C-11]raclopride, NEUROPSYCH, 20(5), 1999, pp. 424-433
Risultati:
1-13
|